Navigation Links
Full Handle Laseredge Stab Blade Knife, 30 blade

ProductsFull Handle Laseredge Stab Blade Knife, 30 blade
Company Bausch & Lomb Storz
Item Full Handle Laseredge Stab Blade Knife, 30 blade
Features 
Description Full Handle Laseredge Stab Blade Knife, 30 blade. Blade tip dimension: 10.5 mm x 1.9 mm x 3.4 mm.
Info Bausch & Lomb Storz
Customer Service: (585) 338-6000
Web site: http://www.storz.com/

Related medicine products :

1. Universal Handle for Blades
2. Universal Trephine Handle with Cottingham Punch
3. Storz Universal Trephine Handle
4. Handle for Corneal Burrs
5. Replacement Handle
6. Thorton Fixation Ring with Handle
7. Full Handle Laseredge Stab Blade Knife, 15 blade
8. Full Handle Laseredge Stab Blade Knife, 15 blade, 3 mm
9. Full Handle Laseredge Stab Blade Knife, 22.5 blade
10. Full Handle Laseredge Stab Blade Knife, 45 blade
11. Full Handle Laseredge Crescent Blade Knife, angled bevel up
...E-T-FILL Capillary Blood Collection Tubes are 100%...able for a wide range of applications, the Capilla...lary tube, attached cap and a micro tube.,The...blood into the micro tube thereby eliminating the ...
...E-T-FILL Capillary Blood Collection Tubes are 100%...able for a wide range of applications, the Capilla...lary tube, attached cap and a micro tube.,The capi... into the micro tube thereby eliminating the tende...
Diagnostic serology for Toxoplasmosis has progressed from the use of a specialized dye test to immunoflourescence, latex and enzyme immunoassay (EIA) techniques. In addition to Toxo IgG indirect EIA
...fective and relatively bloodless procedure for imm...earn and can be performed in less than an hour in ...lications. Surgeons can quickly master the procedu... with which they are comfortable. Patients experie...
Medicine Products:
(Date:10/7/2008)...ncement of planned bequest comes at stem cell symp...swire/ -- Just over one year,ago, retail pioneer A...he,University of Michigan, to endow a new research...eventing human disease., Today, at the institute,...hat he will bequeath an additional $22 million to ...
(Date:10/7/2008)...ed individuals show signs of awareness, unlike veg...hDay News) -- Severely brain-damaged patients in ...and require painkilling treatment, according to Eu...ate (MCS) is different than a persistent vegetativ...awareness of self or surroundings. MCS patients do...
(Date:10/7/2008)...0 Activity Bags Donated to Area Youth in Houston a...USTON, Oct. 7 /PRNewswire/ -- Carlson Hotels World... provide more than 1,900 activity bags,to children...he tote bags,contained a fun activity book, colore...to: http://www.newscom.com/cgi-bin/prnh/20081007/...
(Date:10/7/2008)...ll., Oct. 7 /PRNewswire/ -- Viant, Inc. today anno...nters for Medicare & Medicaid,Services (CMS) that ...ontractor in the national rollout of the Medicare ...s advised the company that contracts were,awarded ...fee bidder that,satisfied CMS,s minimum technical ...
Breaking Medicine News(10 mins):Health News:Alfred Taubman Announces New $22M Gift to U-M 2Health News:Patients in Minimally Conscious State May Still Feel Pain 2Health News:Carlson Hotels Worldwide Partners With the American Red Cross in Texas to Provide Relief for Children Affected by Hurricane Ike 2
...iant tumour weighing over 25 kilogram from the bel... out from a patient in this age group. // The tum...Terathum district, extended from the uterus to the...yesterday, doctors at Birat Nursing Home in south-...
...ported in the United Kingdom, asthmatics will witn...n within two months of completely// staying off ci...The improvement in lung function seen after smokin.... It demonstrates that there is a reversible compo...
...ore prone to develop multiple sclerosis (MS) in co...eveals.// Both type-1 diabetes and MS are auto-im...t immune response against itself, attacking insuli...betes, and the myelin sheath of the neurons in tho...
...ps by which an breastfeeding women who is also ove...that the overweight women who are breastfeeding an...heir target by decreasing the amount of sweetened ...ts in their diet. They have also recommended that ...
Other Medicine News:Health News:Diet & Exercise regime Not Harmful For Overweight, Lactating Mothers Or their Infants 2
(Date:10/7/2008).... 7 /- The Texas Cardiac Arrhythmia,I...been selected as one of,only a few sites in the na...ial for a new device to treat persistent atrial fi...ning and research center specializing in heart,rhy...s Medical Center and,Texas Cardiovascular Consulta...
(Date:10/7/2008)...7 /- CEL-SCI Corporation,(N...to a Material Transfer,Agreement (MTA) with the Na...) and the laboratory of Dr. Francesco M. Marincola...ges to the tumor microenvironment,caused by CEL-SC...ief of,the Infectious Disease and Immunogentics Se...
(Date:10/7/2008)...Oct. 7 /- Taligen Therapeutics Inc.,t... Company,s pipeline,candidates were presented at t..., Switzerland. The data highlighted the candidates...mediated diseases., "These highlighted presentati... at the conference, reveal the deep expertise and ...
(Date:10/7/2008).../- Ardea Biosciences, Inc.,...itled "RDEA119, a Potent,and Highly Selective MEK1...um (DSS) -- induced Chronic Colitis in Mice," was ...ogy (ACG) 2008 Annual Meeting in Orlando,Florida....l study of,RDEA119, the Company,s lead mitogen-act...
Breaking Medicine Technology:Texas Cardiac Arrhythmia Institute at St. David's Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation 2CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 2CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 3In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 2In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 3In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 4Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 2Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 3Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 4Integrity Capital Partners Ranked 2nd Fastest Growing Insurance Related Company in US by Inc Magazine 25631 1Integrity Capital Partners Ranked 2nd Fastest Growing Insurance Related Company in US by Inc Magazine 25631 2Underaged Inebriated Easily Get Drinks at Stadiums 25628 1Underaged Inebriated Easily Get Drinks at Stadiums 25628 2 242M grant awarded to University of Kentucky for research on nanoparticles and human health 4550 1 242M grant awarded to University of Kentucky for research on nanoparticles and human health 4550 2Liver Transplant Program Established At Montefiore 25626 1Liver Transplant Program Established At Montefiore 25626 2Liver Transplant Program Established At Montefiore 25626 3Liver Transplant Program Established At Montefiore 25626 4
...7 /PRNewswire/ -- Portola,Pharmaceuticals, Inc. pr...t at the of Cardiology,s (ACC) 56th Annual Scienti...atelet compound,PRT060128, appeared safe and well...latelet inhibition. , Portola presented the data i...ce with PRT060128, a New Direct-acting, Reversible...
...0% Survival in Valortim-Treated,Animals , PRINCETO...ex,Inc. (Nasdaq: MEDX), a leading monoclonal anti...eld biotechnology company dedicated,to the develop...d,that Valortim, a fully human monoclonal antibody...ion and treatment of anthrax,infection, has been s...
Other Medicine Technology:Portola Pharmaceuticals Presents Positive Phase I Data of Its ADP,Receptor Antagonist at the American College of Cardiology 2Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 2Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 3Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 4Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 5Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 6Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 7